NCT05469542 is a clinical trial of Everbeat Ring in Cardiovascular Diseases, sponsored by Grektek Inc..

Who is sponsoring NCT05469542?

NCT05469542 is sponsored by Grektek Inc..

What drugs are being tested in NCT05469542?

Interventions in NCT05469542: Everbeat Ring.

What condition does NCT05469542 study?

NCT05469542 studies Cardiovascular Diseases.

Is NCT05469542 still recruiting?

NCT05469542 is currently status unknown. Last updated 21 July 2022.

Last reviewed 2022-07-21 · How we verify

NCT05469542

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Everbeat Ring ECG Clinical Concordance Study

Status unknown Last updated 21 July 2022

What this trial tests

trial testing Everbeat Ring in Cardiovascular Diseases in 65 participants. Status unknown.

Timeline

1 August 2022

Primary endpoint
20 September 2022

20 September 2022

Quick facts

Lead sponsor	Grektek Inc.
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	65
Start date	1 August 2022
Primary completion	20 September 2022
Estimated completion	20 September 2022
Sites	1 location across United States

Drugs / interventions tested

Everbeat Ring

Conditions studied

Cardiovascular Diseases — all drugs for Cardiovascular Diseases →

Sponsor

Grektek Inc.

Who can join

Adults 18 to 90, any sex, with Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a cross-sectional observational study conducted in patients referred for routine ECG, to compare output from the everbeat finger-worn ECG device to standard of care (SOC) 12-lead electrocardiography. No intervention is involved in this study. Patients visiting the study site during the study period will be assessed for eligibility on a convenience basis, and observational data will be recorded on those eligible.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

NCT07442578 — Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial · NA · active not recruiting
NCT07426263 — Effectiveness of a Therapeutic Education Program on Female Sexuality in Women Attending Cardiac Rehabilitation. · NA · active not recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07324278 — Hybrid Stroke Rehab With Mirror Priming · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05469542 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Grektek Inc.
Last refreshed: 21 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05469542.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing